Beta-adrenergic drugs (β-blockers) in the environment ‒ new methods of removal

• Autorzy: Rezka P. , Balcerzak W.

Identyfikatory

DOI

10.4467/2353737XCT.15.187.4392

Warianty tytułu

PL

Leki beta-adrenolityczne (β-blokery) w środowisku ‒ nowe metody eliminacji

• Języki publikacji: EN

Abstrakty

EN

This paper is part of a series of publications discussing the prevalence of pharmaceuticals in the aquatic environment and the effectiveness of their removal and degradation during wastewater and water treatment processes. It presents the most commonly used β-blockers and their parameters related to their metabolism and excretion from a body. In the paper, the authors review the literature data on the presence of ß-blockers in wastewater and surface waters and present new solutions which have been developed to increase the efficiency of removal of these compounds from wastewater and potable water.

PL

Artykuł jest częścią serii publikacji obejmujących zagadnienia występowania farmaceutyków w środowisku wodnym oraz skuteczności ich eliminacji i degradacji w procesach oczyszczania ścieków i uzdatniania wody. W pracy przedstawiono najczęściej stosowane leki β-adrenolityczne oraz ich parametry dotyczące metabolizmu i usuwania z organizmu. Dokonano przeglądu literatury dotyczącej występowania ß-blokerów w ściekach i wodach powierzchniowych oraz nowych rozwiązań mających na celu zwiększenie skuteczności eliminacji tych związków ze ścieków i uzdatnianej wody.

Słowa kluczowe

EN

β-blockers; wastewater; surface water; wastewater treatment; water treatment

PL

β-blokery; ścieki; wody powierzchniowe; oczyszczanie ścieków; uzdatnianie wody

• Wydawca: Wydawnictwo Politechniki Krakowskiej im. Tadeusza Kościuszki
• Czasopismo: Czasopismo Techniczne. Środowisko
• Rocznik: 2015
• Tom: Y. 112, iss. 1-Ś
• Strony: 95--102
• Opis fizyczny: Bibliogr. 33 poz., tab.

Twórcy

autor

Rezka P.

• Faculty of Environmental Engineering, Cracow University of Technology

autor

Balcerzak W.

• Faculty of Environmental Engineering, Cracow University of Technology

Bibliografia

• [1] Aydin E., Talinli I., Analysis, occurrence and fate of commonly used pharmaceuticals and hormones in the Buyukcekmece Watershed, Turkey, Chemosphere, Vol. 90, 2013, 2004-2012.
• [2] Balcerzak W., Rezka,P., Occurrence of anti-cancer drugs in the aquatic environment and efficiency of their removal ‒ the selected issues, Technical Transactions, 1-Ś/2014, 11-18.
• [3] Benner J., Helbling D.E., Kohler H.-P.E., Wittebol J., Kaiser E., Prassem C., Ternes T.A., Albers C.N., Aamand J., Horemans B., Springael D., Walravens E., Boon N., Is biological treatment a viable alternative for micropollutant removal in drinking water treatment processes?, Water Research, Vol. 47, 2013, 5955-5976.
• [4] Camacho-Munoz D., Martin J., Santos J.L., Aparicio I., Alonso E., Occurrence, temporal evolution and risk assessment of pharmaceutically active compounds in Doñana Park (Spain), Journal of Hazardous Materials, Vol. 183, 2010, 602-608.
• [5] Gros M., Pizzolato T.-M., Petrovic M., Lopez de Alda M.J., Barcelo D., Trace level determination of b-blockers in waste waters by highly selective molecularly imprinted polymers extraction followed by liquid chromatography-quadrupole-linear ion trap mass spektrometry, Journal of Chromatography A, Vol. 1189, 2008, 374-384.
• [6] Huerta-Fontela M., Galceran M.T., Ventura F., Occurrence and removal of pharmaceuticals and hormones through drinking water treatment, Water Research, Vol. 45, 2011, 1432-1442.
• [7] Huggett D.B., Khan I.A., Foran C.M., Schlenk D., Determination of beta-adrenergic receptor blocking pharmaceuticals in United States wastewater effluent, Environmental Pollution, Vol. 121, 2003, 199-205.
• [8] Huntscha S., Singer H. P., McArdell C.S., Frank C.E., Hollender J., Multiresidue analysis of 88 polar organic micropollutants in ground, surface and wastewater using online mixed-bed multilayer solid-phase extraction coupled to high performance liquid chromatography-tandem mass spectrometry, Journal of Chromatography A, Vol. 1268, 2012, 74-83.
• [9] de Jongh C.M., Kooij P.J.F., de Voogt P., terLaak T.L., Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface water and drinking water, Science of the Total Environment, Vol. 427, 2012, 70-77.
• [10] Li W.C., Occurrence, sources, and fate of pharmaceuticals in aquatic environment and soil, Environmental Pollution 187, 2014, 193-201.
• [11] Lopez-Serna R., Jurado A., Vazquez-Sune E., Carrera J., Petrovic M., Barcelo D., Occurrence of 95 pharmaceuticalss and transformation products in urban groundwaters underlying the metropolis of Barcelona, Spain, Environmental Pollution, Vol. 174, 2013, 305-315.
• [12] Luo Y., Guo W., Ngo H.H., Nghiem L.D., Hai F.I., Zhang J., Liang S., Wang X.C., A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment, Science of the Total Environment, Vol. 473‒474, 2014, 619-641.
• [13] MacLeod S.L., Sudhir P., Wong C.S., Stereoisomer analysis of wastewater-derived b-blockers, selective serotonin re-uptake inhibitors, and salbutamol by high-performance liquid chromatography-tandem mass spectrometry, Journal of Chromatography A, Vol. 1170, 2007, 23-33.
• [14] Maszkowska J., Stolte S., Kumirska J., Łukaszewicz P., Mioduszewska K., Puckowski A., Caban M., Wagil M., Stepnowski P., Białk-Bielińska A., Beta-blockers in the environment Part I. Mobility and hydrolysis study, Science of the Total Environment, Vol. 493, 2014, 1112-1121.
• [15] Nodler K., Hillebrand O., Idzik K., Strathmann M., Schiperski F., Zirlewagen J., Licha T., A comparative study with selected β-blockers and the persistent anthropogenic wastewater indicators carbamazepine and acesulfame, Water Research, Vol. 47, 2013, 6650-6659.
• [16] Petrie B., Barden R., Kasprzyk-Hodern,B., A review on emerging contaminants in wastewaters and the environment: Current knowledge, understudied areas and recommendations for future monitoring, Water Research, Vol. 72, 2015, 3-27.
• [17] Rezka P., Balcerzak W., The occurrence of non-steroidal anti-inflammatory drugs in wastewater and water environment and methods of their removal – selected issues, Archives of Waste Management and Environmental Protection, Vol. 17(1), 2015, 33-38.
• [18] Salem A.A., Wasfi I.A., Al-Nassibi S.S., Trace determination of β-blockers and β2-agonists in distilled and waste-waters using liquid chromatography–tandem mass spectrometry and solid-phase extraction, Journal of Chromatography B, Vol. 908, 2012, 27-38.
• [19] Shao B., Chen D., Zhang J., Wu Y., Sun C., Determination of 76 pharmaceutical drugs by liquid chromatography–tandem mass spectrometry in slaughterhouse wastewater, Journal of Chromatography A, Vol. 1216, 2009, 8312-8318.
• [20] Verlicchi P., Al Aukidy M., Galletti A., Petrovic M., Barcelo D., Hospital effluent ‒ Investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment, Science of the Total Environment, Vol. 430, 2012, 109-118.
• [21] Verlicchi P., Al Aukidy M., Zambello E., What have we learned from worldwide experiences on the management and treatment of hospital effluent, Science of the Total Environment, Vol. 514, 2015, 467-491.
• [22] Węgrzyn A., Machura M., Żabczyński S., Możliwości usuwania środków cieniujących ze ścieków, Ochrona Środowiska, Vol. 37(1), 2015, 55-63.
• [23] Wilde M.L., Mahmoud W.M.M., Kummerer K., Martins A.F., Oxidation–coagulation of β-blockers by K2FeVIO4 in hospital wastewater ‒ Assessment of degradation products and biodegradability, Science of the Total Environment, Vol. 452-453, 2013, 137-147.
• [24] Yu Y., Liu Y., Wu X., Weng Z., Hou Y., Wu L., Enhanced visible light photocatalytic degradation of metoprolol by Ag–Bi2WO6–graphene composite, Separation and Purification Technology, Vol. 142, 2015, 1-7.
• [25] Acebutolol, www.drugbank.ca/drugs/DB01193, online: 31.05.2015.
• [26] Atenolol, www.drugbank.ca/drugs/DB00335, online: 31.05.2015.
• [27] Betaxolol, www.drugbank.ca/drugs/DB00195, online: 31.05.2015.
• [28] Bisoprolol, www.drugbank.ca/drugs/DB00612, online: 31.05.2015.
• [29] Metoprolol, www.drugbank.ca/drugs/DB00264, online: 31.05.2015.
• [30] Nadolol, www.drugbank.ca/drugs/DB01203, online: 31.05.2015.
• [31] Propranolol, www.drugbank.ca/drugs/DB00571, online: 31.05.2015.
• [32] Sotalol, www.drugbank.ca/drugs/DB00489, online: 31.05.2015.
• [33] Timolol, www.drugbank.ca/drugs/DB00373, online: 31.05.2015.